Hematology and Oncology
Home Hematology and Oncology
Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
By Ernie Mundell HealthDay Reporter
THURSDAY, May 2, 2024 (HealthDay News) -- Johnson & Johnson announced Wednesday that it would pay out more than $6.5...
Healthy Lifestyle Can Overcome Genetic Predisposition to Premature Death
Optimal healthy lifestyles include never smoking, regular physical activity, adequate sleep duration, and a healthy diet
Biden Administration Could Reclassify Marijuana as Less Risky Drug
By Robin Foster HealthDay Reporter
WEDNESDAY, May 1, 2024 (HealthDay News) -- The Justice Department has recommended that marijuana be reclassified as a less dangerous...
USPSTF Recommends Breast Cancer Screening for Women Aged 40 to 75 Years
Insufficient evidence seen for screening older women and for supplemental screening for women with dense breasts
Survival Gains Seen With Assignment to Experimental Group in Cancer Trials
Statistically significant survival gains observed for patients with solid tumors assigned to experimental group
Variation ID’d in Risk for Second Primary Cancer After Breast Cancer
Risk for second primary cancer after breast cancer higher for women, especially those who were younger at BC diagnosis
People With Opioid Use Disorder Less Likely to Receive Palliative Care
Difference did not persist after exclusion of people who died suddenly
Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
Overall response rate was 25.0 percent in phase 2 study involving 17 patients
More Medical Lab Tests Will Soon Face Federal Scrutiny, FDA Says
By Ernie Mundell HealthDay Reporter
MONDAY, April 29, 2024 (HealthDay News) -- Laboratory tests used by millions of Americans are soon to be classified as...
Cabozantinib Promising for Advanced Adrenocortical Carcinoma
Promising efficacy seen with a manageable safety profile in phase 2 study involving 18 patients